|
Novo Nordisk’s Wegovy pill is already providing financial fuel in the company’s bid to catch Eli Lilly.
|
 |
|
This deal strengthens GSK’s focus on addressing the complications of obesity, while restocking the company’s pipeline amid key patent expiries.
|
|
|
The acquisition involves Angelini Pharma purchasing all outstanding Catalyst shares for $31.50 per share in cash.
|
|
|
The site is expected to be operational in 2028, adding new roles in advanced manufacturing and bioengineering.
|
|
|
When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients.
|
|
